DDD Partners LLC Raises Position in Danaher Corporation $DHR

DDD Partners LLC lifted its stake in shares of Danaher Corporation (NYSE:DHR) by 7,732.8% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 92,270 shares of the conglomerate’s stock after acquiring an additional 91,092 shares during the period. Danaher makes up 1.2% of DDD Partners LLC’s holdings, making the stock its 27th biggest holding. DDD Partners LLC’s holdings in Danaher were worth $18,293,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of DHR. WFA of San Diego LLC acquired a new position in shares of Danaher during the second quarter worth $26,000. Howard Hughes Medical Institute acquired a new position in Danaher in the 2nd quarter worth $27,000. TruNorth Capital Management LLC purchased a new position in Danaher in the 3rd quarter valued at about $28,000. Tripletail Wealth Management LLC acquired a new stake in shares of Danaher during the third quarter valued at about $31,000. Finally, Heartwood Wealth Advisors LLC acquired a new position in shares of Danaher in the third quarter worth about $37,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on DHR. Evercore restated an “outperform” rating and set a $254.00 price objective on shares of Danaher in a report on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a research note on Monday, December 29th. Robert W. Baird set a $251.00 target price on shares of Danaher in a research report on Thursday, January 29th. Finally, TD Cowen restated a “buy” rating on shares of Danaher in a research note on Wednesday, January 7th. Twenty analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average price target of $253.86.

Danaher Stock Performance

Shares of NYSE DHR opened at $212.37 on Friday. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $242.80. The company has a market cap of $150.01 billion, a PE ratio of 42.14, a P/E/G ratio of 2.90 and a beta of 0.91. The stock has a 50 day simple moving average of $228.63 and a 200-day simple moving average of $215.46. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The firm had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. During the same quarter in the previous year, the business earned $2.14 EPS. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. On average, equities research analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Friday, December 26th were given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date was Friday, December 26th. Danaher’s dividend payout ratio is currently 25.40%.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 3,298 shares of the business’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the sale, the director directly owned 20,762 shares in the company, valued at approximately $4,702,593. The trade was a 13.71% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.